Nephros

GenArraytion Inc. is a veteran-owned small business based in Rockville, Maryland, specializing in molecular genotyping technologies for medical diagnostics. The company provides a range of products and services that focus on tick- and mosquito-borne diseases, epidemiology, source tracking, food and water testing, biodefense, and environmental monitoring. GenArraytion's offerings include MultiFLEX Bioassays and Sniper Sequencing genotyping services, which facilitate rapid and precise detection of infectious diseases, thereby enhancing response and treatment strategies. The company has developed advanced real-time multiplexed PCR assays, multiplexed bead-based assays, and custom microarrays, enabling simultaneous detection of multiple pathogens and antimicrobial characterization. GenArraytion is actively registered in the CCR database and holds ORCA certification.

Biocon Limited, established in 1978 and headquartered in Bengaluru, India, is a fully integrated biopharmaceutical company. It specializes in the development, manufacturing, and commercialization of a wide range of biopharmaceuticals, including biosimilars, novel biologics, and complex small molecule APIs. Biocon's portfolio spans recombinant human insulin, insulin analogs, monoclonal antibodies, and therapeutic proteins, targeting areas like diabetes, oncology, and immunology. The company operates through four segments: Biosimilars, Generics, Novel Biologics, and Research Services. It also offers contract research and manufacturing services to the pharmaceutical industry through its subsidiary, Syngene. Biocon's mission is to expand patient access to affordable, high-quality biopharmaceuticals, driven by a commitment to innovation and humanitarian responsibility.